Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Vertex pattern hair loss linked to higher prostate cancer risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Certain natural compounds called terpenes may help prevent prostate cancer.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

No link was found between hair patterns and prostate cancer risk in South Indian men.

Certain genetic markers may increase or decrease prostate cancer risk.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

The new method found new shared genetic areas linked to both Type 2 Diabetes and Prostate Cancer.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.